Showing 11-20 of 102 results for "".
The Mind-Skin Connection: Psoriasis and Psychological Comorbidities
https://practicaldermatology.com/issues/supplements/the-mind-skin-connection-psoriasis-and-psychological-comorbidities/20833/Inflammatory Responses: Managing Psoriasis in Light of Comorbidities
https://practicaldermatology.com/topics/psoriasis/inflammatory-responses-managing-psoriasis-in-light-of-comorbidities/20440/The accumulated evidence suggests that dermatologists must take an active role in addressing risks.Advances in Topical Acne Therapy
https://practicaldermatology.com/topics/practice-management/advancesin-topical-acne-therapy/21020/Even severe acne patients can be safely—and effectively—treated with topicals today.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments/20495/Prescriber, Beware: Understanding and Protecting Drug Compounding
https://practicaldermatology.com/topics/practice-management/prescriber-beware-understanding-and-protecting-drug-compounding/20582/Compounding has been an integral part of the specialty, but changing regulations and new players may converge to bring change.Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-5/23092/OTC Skincare Today
https://practicaldermatology.com/issues/supplements/otc-skincare-today/23247/Can dermatologists afford to ignore patients’ growing use of OTC products?Therapeutic Review: A Host of New Treatments Emerged in 2018
https://practicaldermatology.com/topics/psoriasis/therapeutic-review-a-host-of-new-treatments-emerged-in-2018/20381/Here's a handy reference to new drugs and devices—and other key developments—this year.Recent Developments
https://practicaldermatology.com/columns/recent-developments/news/20326/- KYTHERA Biopharmaceuticals to Present at 32nd Annual J.P. Morgan Healthcare Conferencehttps://practicaldermatology.com/news/20140107-kythera_biopharmaceuticals_to_present_at_32nd_annual_jp_morgan_healthcare_conference/2459378/KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the 32nd Annual J.P. Morgan Healthcare Conference in San Francisco, CA.